Subiaco-based PharmAust Ltd, through its wholly owned subsidiary Epichem Pty Ltd, has entered into a joint venture agreement with Curtin University to develop oral insulin for the treatment of diabetes.
04/11/2008 - 11:31
PharmAust, Curtin in diabetes JV
04/11/2008 - 11:31
![](https://images.businessnews.com.au/images/bn2020/bubble-arrow-border.png)